Literature DB >> 25804470

c-Cbl inhibition: A novel therapeutic approach for attenuating myocardial ischemia and reperfusion injury.

Jichun Wang1, Li Li2, Hong Jiang3.   

Abstract

Entities:  

Keywords:  Cardiac remodeling; Casitas B-lineage lymphoma-b (c-Cbl); Myocardial ischemia and reperfusion injury

Mesh：

Substances：

Year:  2015        PMID： 25804470     DOI： 10.1016/j.ijcard.2015.03.254

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

1.  Erythropoietin pretreatment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocardial ischemia-reperfusion injury.

Authors:  Ren Rong; Xiao Xijun
Journal:  Exp Ther Med       Date:  2015-05-29       Impact factor: 2.447

Review 2.  Cracking the Monoubiquitin Code of Genetic Diseases.

Authors:  Raj Nayan Sewduth; Maria Francesca Baietti; Anna A Sablina
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.